Insulin-deficient conditions in T1DM are typically associated with low levels and/or action of IGF-1, which have an adverse effect on osteoblasts during growth and can result in low peak bone mass at an early age (85–87). This evidence concerns the gene INS and type 1 diabetes mellitus.